Celltrion HealthCare Co Ltd operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion HealthCare Co Ltd with three other
drug stores in Asia:
Hokuyaku Takeyama Holdings, Inc
sales of 243.10 billion Japanese Yen [US$2.21 billion]
of which 68%
was Pharmaceutical Business),
Enseval Putera Megatrading Tbk PT
(22.55 trillion Indonesian Rupiahs [US$1.58 billion]
of which 44%
was Consumer Products), and
Hanmi Science Company Limited
(857.38 billion Korean Won [US$766.50 million]
of which 96%
was Pharmaceutical Sales).
During the first
quarter of 2021, sales at Celltrion HealthCare Co Ltd totalled
356.29 billion Korean Won .
This is a drop of 0.2%
from the 356.90 billion Korean Won in sales at the company during the first quarter in 2020.
Celltrion HealthCare Co Ltd reported sales of 1.63 trillion Korean Won (US$1.46 billion)
December of 2020.
increase of 47.8%
versus 2019, when the company's sales were 1.10 trillion Korean Won .